Pacer Advisors Inc. lowered its stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 35.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,790 shares of the health services provider’s stock after selling 3,183 shares during the quarter. Pacer Advisors Inc.’s holdings in Maximus were worth $395,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the stock. Mackenzie Financial Corp raised its stake in shares of Maximus by 2.0% during the 4th quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider’s stock worth $207,687,000 after purchasing an additional 55,583 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock worth $105,001,000 after purchasing an additional 177,075 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in Maximus by 7.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider’s stock valued at $92,188,000 after purchasing an additional 84,835 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of Maximus by 2.0% in the 4th quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider’s stock worth $88,546,000 after acquiring an additional 22,711 shares in the last quarter. Finally, Reinhart Partners LLC. raised its position in Maximus by 65.4% in the first quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider’s stock worth $62,156,000 after acquiring an additional 360,365 shares during the period. 97.21% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, May 15th.
Insider Transactions at Maximus
In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the firm’s stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares of the company’s stock, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is currently owned by insiders.
Maximus Price Performance
NYSE:MMS opened at $72.84 on Friday. The stock has a market cap of $4.10 billion, a PE ratio of 14.48 and a beta of 0.61. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.94. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87. The business’s 50-day simple moving average is $71.31 and its two-hundred day simple moving average is $70.55.
Maximus (NYSE:MMS – Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a net margin of 5.56% and a return on equity of 23.37%. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.57 earnings per share. As a group, analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Friday, August 15th. Maximus’s dividend payout ratio (DPR) is presently 23.86%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- How to Find Undervalued Stocks
- Will Hims & Hers Fall Along With Novo Nordisk?
- How Investors Can Find the Best Cheap Dividend Stocks
- Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
- P/E Ratio Calculation: How to Assess Stocks
- Rocket Lab Reports Next Week: Here’s What Investors Should Know
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.